UNCY
Unicycive Therapeutics Inc
NASDAQ: UNCY · HEALTHCARE · BIOTECHNOLOGY
$7.66
+6.98% today
Updated 2026-04-30
Market cap
$180.96M
P/E ratio
—
P/S ratio
23.75x
EPS (TTM)
$-1.67
Dividend yield
—
52W range
$4 – $11
Volume
0.5M
Unicycive Therapeutics Inc (UNCY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-141.10%
ROA
-45.70%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-1.12M | — | — | — |
| 2019 | $0.00 | $-2.30M | — | — | — |
| 2020 | $0.00 | $-2.51M | — | — | — |
| 2021 | $0.00 | $-10.63M | — | — | — |
| 2022 | $951000.00 | $-18.06M | 100.00% | -1,898.21% | -1,899.47% |
| 2023 | $675000.00 | $-30.54M | 100.00% | -3,077.63% | -4,525.04% |
| 2024 | $0.00 | $-36.73M | — | — | — |
| 2025 | $0.00 | $-26.55M | — | — | — |